Leaps by Bayer

Breaking Through Impossible


How can we tackle some of humanity’s biggest challenges across healthcare and agriculture? Leaps by Bayer is spearheading a movement to make paradigm-shifting advances in the life sciences – targeting the breakthroughs that could fundamentally change the world for the better.

Across healthcare and agriculture, Leaps is aiming to conquer ten huge challenges, ’10 Leaps’, facing humanity, such as reducing the environmental impact of agriculture or curing genetic diseases. These ’10 Leaps’ build the framework for Leaps impact investment strategy.

Leaps by Bayer Chapter III: Leap Forward – a leap into tomorrow. World-record-holder Olivia Jenkins teamed up with weather scientist Dr. Alicia Ageno to make a seemingly impossible journey: crossing the international date line.

Collaborating with the most visionary founders in the industry

Leaps collaborates with the world’s brightest minds in biotech, health-tech and ag-tech. Leaps invests in existing companies or co-creating new ventures, providing significant early-stage funding and access to the Bayer network’s technical capabilities and 150 years of expertise. This unique approach allows the companies to focus on the long-term delivery of their disruptive technology.


Since 2015, Leaps by Bayer has invested over $1.7 billion in over 55 ventures working on disruptive innovations.


In the agricultural sector, these companies tackle fundamental breakthroughs to drive next-generation agriculture technologies that provide solutions to sustainably meet the demands of our growing population.


In the healthcare sector, the ultimate goal of these investments is to move from treatment to prevention and cure, addressing some of the most devastating diseases.

In conversations with Leaps team members and portfolio company leaders, Head of Leaps by Bayer, Juergen Eckhardt, highlights how they aim to enable great ideas to develop into breakthroughs in science and leap forward to the future.